Xtressé Hair Growth Gummies for hair density in women with thinning hair

You may qualify if

• Self-perceived thinning hair, confirmed by the investigator as Ludwig I or II
• Fitzpatrick skin types I to IV
• Stable thinning for at least 6 months
• No use of other hair loss treatment during participation. Stopped prior -treatments 3-6 months before participation.
• Willing to keep hair, length, color, and style comparable through Day 180.
• Willing to use contraception through day 180 if or childbearing potential.
• Able to attend all in-person study visits

You can't join if

• Scalp disease that is clinically significant, involves the target area, or would interfere with assessment.
• Alopecia areata, active telogen effluvium, or other non-androgenetic hair loss.
• Prior hair transplant.
• Pregnant, breastfeeding, planning pregnancy during the study, or gave birth within the past 12 months.
• Hormone therapy started or changed within 3 months before Day 0.
• GLP-1 receptor agonist use, unless the dose has been stable and body weight has changed by no more than 5% for at least 6 months.
• Weight change of more than 10% within 6 months before Day 0.
• Oral isotretinoin within 6 months before Day 0.
• Major illness, surgery, or other recognized shedding trigger within 6 months before Day 0.
• Bleeding or clotting disorder, or anticoagulant or antiplatelet therapy other than aspirin at 81 mg or less daily.
• Active liver disease, or poorly controlled diabetes, hypertension, or thyroid disease.
• Active malignancy or systemic immunosuppressant use.
• Known allergy to any ingredient in the active or placebo gummy.
• Unwilling to stop other supplements containing ashwagandha, turmeric, saw palmetto, or high-dose vitamins and minerals during the study.
• Participation in another clinical study within 30 days before Day 0.
• Any other condition the investigator judges would put the subject at risk or compromise the data.